Pharma firm hikes life-saving drug price by 5,500%
The medical community is outraged by a 5,500 percent price hike for
Daraprim, after a big NY-based pharmaceutical company purchased the
patent for it. The drug has been on the market for over 60 years, and
can be essential to certain AIDS and cancer treatments.
The New York-based Turing Daraprim, after a big NY-based pharmaceutical company purchased the
patent for it. The drug has been on the market for over 60 years, and
can be essential to certain AIDS and cancer treatments.
Pharmaceuticals raised the price of Daraprim from $13.50 to $750 per
pill in just over a month after buying the rights for the drug from
Impax Laboratories.
The drug is used to treat toxoplasmosis, the
second most common food-borne disease that affects patients suffering
from AIDS and cancer. It has been produced since 1953 and is on the WHO
List of Essential Medicines. But now medical associations are beating
their drums about the sudden price hike and potential affordability of
Daraprim as a treatment.
